Search

Author/Creator Frigerio, Mark

1. Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4. Issue 7 (3rd October 2019)

Authors:
Griffiths, Katherine; Binder, Uli; McDowell, William; Tommasi, Rita; Frigerio, Mark; Darby, William G.; Hosking, Chris G.; Renaud, Lionel; Machacek, Matthias; Lloyd, Peter; Skerra, Arne; Foley, Michael
Journal:
MAbs
Issue:
Volume 11:Issue 7(2019)
Page Start:
1331
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antitumor imidazo[5, 1-d]-1, 2, 3, 5-tetrazines: compounds modified at the 3-position overcome resistance in human glioblastoma cell lines12. Issue 12 (3rd October 2016)

Authors:
Cousin, David; Zhang, Jihong; Hummersone, Marc G.; Matthews, Charles S.; Frigerio, Mark; Bradshaw, Tracey D.; Stevens, Malcolm F. G.
Journal:
MedChemComm
Issue:
Volume 7:Issue 12(2016:Dec.)
Page Start:
2332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search